![]() |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
The Division of Nutrition
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Wednesday, March 15, 2006
|
||
| 7:30 AM | Registration & Continental Breakfast | |
| 8:00 | Welcome | W. Allan Walker, M.D. Conrad Taff Professor of Nutrition; Director, Division of Nutrition, Harvard Medical School |
| 8:05 | Introductory remarks | George Blackburn, M.D., Ph.D. S. Daniel Abraham Associate Professor of Nutrition; Associate Director, Division of Nutrition, Harvard Medical School |
|
SESSION I: METABOLIC SYNDROME (MS) AND CANCER RISK: EPIDEMIOLOGICAL INVESTIGATION
|
Moderator: John Milner, Ph.D. Chief of the Nutrition Science Research Group in the Division of Cancer Prevention at the National Cancer Institute |
|
| 8:10 | Epidemiological Evidence on MS and Cancer Development: An Overview of Epidemiological Evidence and Proposed Mechanics | Eugenia E. Calle, Ph.D. American Cancer Society |
| 8:55 | The Role of IGF-I Signaling in Cancer Risk and Progression: A Connection Between MS and Cancer Risk | Michael N. Pollak, M.D., FRCP McGill University |
| 9:20 | Diabetes, MS and Risk of Breast Cancer | Karin Michels, Sc.D., Ph.D., Brigham and Women's Hospital, Harvard Medical School |
| 9:50 | Break | |
| 10:05 | MS, Obesity and Risk of Colon Cancer | Edward L. Giovannucci, D.Sc., M.D., Harvard School of Public Health |
| 10:30 | MS, Obesity and Risk of Prostate Cancer | Ann Hsing, Ph.D., National Cancer Institute |
| 10:55 | Panel Discussion | |
| 11:30 | Lunch | |
|
SESSION II:
BASIC RESEARCH |
Moderator: Jin-Rong Zhou, PhD, Assistant Professor of Surgery, Harvard Medical School; Director, Nutrition/Metabolism Lab, Beth Israel Deaconess Medical Center | |
| 1:00 | PI3K-Akt: A Central Pathway in Both Turmorigenesis and Insulin Signaling | Lewis C. Cantley, Ph.D., Beth Israel Deaconess Medical Center, Harvard Medical School |
| 1:15 | The Role of Adiponectin in Cancer Development and Progression | Christos S. Mantzoros, M.D., Beth Israel Deaconess Medical Center, Harvard Medical School |
| 1:40 | Free Fatty Acids, Insulin Resistance and Cancer | Richard N. Bergman, Ph.D., University of Southern California School of Medicine |
| 2:05 | The Role of AMPK in MS and Cancer | Neil B. Ruderman, M.D., Boston University Medical Center |
| 2:30 | The Potential Role of MS in Epigenetic Modulation of Carcinogenesis | Sharon A. Ross, Ph.D., M.P.H., National Cancer Institute |
| 2:55 | The Role of Stress and Inflammatory Pathways in Metabolic Homeostasis and Survival | Gokhan Hotamisligil, M.D., Ph.D., Harvard School of Public Health |
| 3:25 | Panel Discussion | |
| 4:15 PM | Adjourn for the day | |
|
Thursday, March 16
|
||
| 7:30 AM | Registration and Continental Breakfast | |
|
SESSION III:
PREVENTION AND INTERVENTION: Preclinical and Clinical Studies |
Moderator: George L. Blackburn, M.D, Ph.D., S. Daniel Abraham Associate Professor of Nutrition; Associate Director, Division of Nutrition, Harvard Medical School | |
| 8:00 | Dietary Fat Reduction and Breast Cancer Outcome: Results from the Women's Intervention Nutrition Study (WINS) | George L. Blackburn, M.D, Ph.D.. Harvard Medical School Division of Nutrition |
| 8:30 | Dietary and Nutritional Combinations and Cancer Prevention: Targeting MS | Jin-Rong Zhou, Ph.D. |
| 9:00 | Insulin Sensitizers and Cancer Prevention and Treatment: PPAR-gamma Agonists | Bruce Spiegelman, Ph.D., Harvard Medical School, Dana Farber Cancer Institute |
| 9:30 | Prostate Cancer Prevention by Nutritional Means to Alleviate MS | R. James Barnard, Ph.D., UCLA |
| 10:00 | Panel Discussion | |
| 10:30 | Break | |
|
SESSION IV: TRANSLATIONAL AND CLINICAL SCIENCE
|
||
| 10:50 | WHI Summary and Dietary Implications |
John Milner, Ph.D., |
| 11:00 | Panel Discussion | |
| 12:00 | Closing Remarks | Dr. Walker and Dr. Blackburn |
| Symposium Adjourns | ||
Although there is no fee for the symposium, lunch and refreshments, registration is required. A limited number of discounted rooms ($139) at the adjoining Best Western Inn at Longwood Medical Center, 342 Longwood Ave., Boston MA, 02115 may be reserved by calling (617) 731-4700. In order to receive that rate let them know you are attending Harvard Medical School’s "Metabolic Syndrome" Symposium
Click HERE for an Introduction to this event.